AlphaFold: An emerging tool for drug development in oral cancer - 19/09/25
Doi : 10.1016/j.jormas.2025.102414
Lucas Alves da Mota Santana a, ⁎ 
, Lara Góis Floresta b, Rajiv Gandhi Gopalsamy c, Bernardo Ferreira Brasileiro a, d, Cleverson Luciano Trento a, Lysandro Pinto Borges e
, Lara Góis Floresta b, Rajiv Gandhi Gopalsamy c, Bernardo Ferreira Brasileiro a, d, Cleverson Luciano Trento a, Lysandro Pinto Borges e a Department of Dentistry, Federal University of Sergipe (UFS), Aracaju, SE, Brazil
b Department of Dentistry, Tiradentes University (UNIT), Aracaju, SE, Brazil
c Division of Phytochemistry and Drug Design, Department of Biosciences, Rajagiri College of Social Sciences, Kochi, Kerala, India
d Oral and Maxillofacial Surgeon, Private Practice, Southwest Florida Oral and Facial Surgery, Fort Myers, Florida, USA
e Department of Pharmacy, Federal University of Sergipe (UFS), São Cristóvão, SE, Brazil
⁎Corresponding author at: Department of Dentistry, Federal University of Sergipe (UFS), Rua Cláudio Batista, s/n, Santo Antônio 49060102 Aracaju, SE, BrazilDepartment of Dentistry, Federal University of Sergipe (UFS)Rua Cláudio Batista, s/n, Santo AntônioAracajuSE49060102Brazil
Keywords : Artificial Intelligence, Oral Cancer, Treatment
Le texte complet de cet article est disponible en PDF.
Plan
© 2025
Elsevier Masson SAS. Tous droits réservés.
Vol 126 - N° 5
Article 102414- octobre 2025 Retour au numéro
Article précédent
- Evaluation of stromal mucin expression in oral submucous fibrosis and its progression to oral squamous cell carcinoma
- Sujitha A, Pratibha Ramani, Suvarna K Nair
- Corrigendum to “What prognostic factors have impacted the efficacy of immune checkpoint inhibitors in patients with recurrent or metastatic oral cancer?” [J Stomatol Oral Maxillofac Surg 125 (2024) 101961]
- Shogo Kikuta, Yushi Abe, Kiyosato Hino, Sho Imai, Katsuhisa Matsuo, Katsumi Shinozaki, Moriyoshi Nakamura, Naoko Seki, Jingo Kusukawa
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?